Alexander Kohlmann

Alexander Kohlmann is currently the Executive Director of Precision Medicine at AstraZeneca, where they lead the Oncology Precision Medicine Franchise. They previously served as a Senior Director at AstraZeneca and also held roles as the Laboratory Director at MLL Münchner Leukämielabor GmbH, overseeing next-generation sequencing and microarrays. Prior to that, Alexander worked as a Research Alliance Manager at Roche Diagnostics, contributing to the development of diagnostic gene expression biomarkers. Alexander holds a PhD in Biology from Ludwig-Maximilians Universität München and a Diplom in Biology from Julius-Maximilians-Universität Würzburg.